2. Signaling Pathways
  3. Protein Tyrosine Kinase/RTK
  4. Tie2

Tie2

Angiopoietin-1 receptor; CD202b

 

Tie2 Related Products (2):

Cat. No. Product Name Effect Purity
  • HY-P99330
    Vanucizumab
    		Inhibitor
    Vanucizumab is a first-in-class, bispecific IgG1-like monoclonal antibody that simultaneously blocks VEGF-A and angiopoietin-2 (Ang-2) from interacting with their receptors. Vanucizumab has antiangiogenic and anticancer effects.
  • HY-P99510
    Zansecimab
    		Inhibitor
    Zansecimab (LY-3127804) is an immunoglobulin G4-kappa, a monoclonal antibody against angiopoietin 2 (Ang 2). Zansecimab has potential applications in angiogenesis and immune regulation.